Literature DB >> 25208072

Perspective: The screening imperative.

John K Field1.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 25208072     DOI： 10.1038/513S7a

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  6 in total

1.  Reduced lung-cancer mortality with low-dose computed tomographic screening.

Authors:  Denise R Aberle; Amanda M Adams; Christine D Berg; William C Black; Jonathan D Clapp; Richard M Fagerstrom; Ilana F Gareen; Constantine Gatsonis; Pamela M Marcus; JoRean D Sicks
Journal:  N Engl J Med       Date:  2011-06-29       Impact factor: 91.245

2.  Management of lung nodules detected by volume CT scanning.

Authors:  Rob J van Klaveren; Matthijs Oudkerk; Mathias Prokop; Ernst T Scholten; Kristiaan Nackaerts; Rene Vernhout; Carola A van Iersel; Karien A M van den Bergh; Susan van 't Westeinde; Carlijn van der Aalst; Erik Thunnissen; Dong Ming Xu; Ying Wang; Yingru Zhao; Hester A Gietema; Bart-Jan de Hoop; Harry J M Groen; Geertruida H de Bock; Peter van Ooijen; Carla Weenink; Johny Verschakelen; Jan-Willem J Lammers; Wim Timens; Dik Willebrand; Aryan Vink; Willem Mali; Harry J de Koning
Journal:  N Engl J Med       Date:  2009-12-03       Impact factor: 91.245

Review 3.  Screening for lung cancer with low-dose computed tomography: a systematic review to update the US Preventive services task force recommendation.

Authors:  Linda L Humphrey; Mark Deffebach; Miranda Pappas; Christina Baumann; Kathryn Artis; Jennifer Priest Mitchell; Bernadette Zakher; Rongwei Fu; Christopher G Slatore
Journal:  Ann Intern Med       Date:  2013-09-17       Impact factor: 25.391

Review 4.  CT screening for lung cancer: countdown to implementation.

Authors:  John K Field; David M Hansell; Stephen W Duffy; David R Baldwin
Journal:  Lancet Oncol       Date:  2013-12       Impact factor: 41.316

Review 5.  Prospects for population screening and diagnosis of lung cancer.

Authors:  John K Field; Matthijs Oudkerk; Jesper Holst Pedersen; Stephen W Duffy
Journal:  Lancet       Date:  2013-08-24       Impact factor: 79.321

6.  Translation of research results to simple estimates of the likely effect of a lung cancer screening programme in the United Kingdom.

Authors:  S W Duffy; J K Field; P C Allgood; A Seigneurin
Journal:  Br J Cancer       Date:  2014-02-13       Impact factor: 7.640
  6 in total
  5 in total

1.  Screening for Lung Cancer: Balancing Hope With Doubt About Applicability.

Authors:  Hans-Werner Hense
Journal:  Dtsch Arztebl Int       Date:  2015-09-18       Impact factor: 5.594

Review 2.  Risk assessment in relation to the detection of small pulmonary nodules.

Authors:  John K Field; Michael W Marcus; Matthijs Oudkerk
Journal:  Transl Lung Cancer Res       Date:  2017-02

Review 3.  [Prerequisites for a successful lung cancer screening program].

Authors:  N Becker; S Delorme
Journal:  Radiologe       Date:  2016-09       Impact factor: 0.635

4.  Ultrasensitive Luminescent In Vitro Detection for Tumor Markers Based on Inorganic Lanthanide Nano-Bioprobes.

Authors:  Wei Zheng; Shanyong Zhou; Jin Xu; Yongsheng Liu; Ping Huang; Yan Liu; Xueyuan Chen
Journal:  Adv Sci (Weinh)       Date:  2016-10-20       Impact factor: 16.806

5.  UK Lung Cancer RCT Pilot Screening Trial: baseline findings from the screening arm provide evidence for the potential implementation of lung cancer screening.

Authors:  J K Field; S W Duffy; D R Baldwin; D K Whynes; A Devaraj; K E Brain; T Eisen; J Gosney; B A Green; J A Holemans; T Kavanagh; K M Kerr; M Ledson; K J Lifford; F E McRonald; A Nair; R D Page; M K B Parmar; D M Rassl; R C Rintoul; N J Screaton; N J Wald; D Weller; P R Williamson; G Yadegarfar; D M Hansell
Journal:  Thorax       Date:  2015-12-08       Impact factor: 9.139
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.